TC BioPharm (Holdings) PLC (TCBP)
1.13
-0.01
(-0.88%)
USD |
NASDAQ |
May 17, 16:00
1.13
0.00 (0.00%)
Pre-Market: 20:00
TC BioPharm Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | 2.218M |
September 30, 2021 | 2.211M |
Date | Value |
---|---|
December 31, 2020 | 2.068M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.068M
Minimum
Dec 2020
2.218M
Maximum
Dec 2021
2.166M
Average
2.211M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 35.21M |
Biodexa Pharmaceuticals Plc | -- |
NuCana PLC | 8.519M |
Autolus Therapeutics PLC | 25.16M |
Mereo BioPharma Group PLC | 3.994M |